1. Europe's court allows access to communications between Pfizer's CEO and EU leaders. 2. The ruling could influence public perception about Pfizer's vaccine contracts.
The ruling may lack immediate financial implications for Pfizer. Historically, transparency in governmental dealings can lead to increased scrutiny but does not always affect stock prices directly.
Public scrutiny over vaccine contracts might impact Pfizer's reputation, which can influence investor sentiment.
While the news could lead to immediate public and media attention, it is not expected to lead to lasting price changes.